Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
07/1995
07/06/1995WO1995017906A1 Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof
07/06/1995WO1995017905A1 Ileal bile acid transporter compositions and methods
07/06/1995WO1995017904A2 Botulinum toxins for treating various disorders and associated pain
07/06/1995WO1995017903A1 Modular design and synthesis of oxazolone-derived molecules
07/06/1995WO1995017886A1 Water soluble non-immunogenic polyamide cross-linking agents
07/06/1995WO1995017885A1 Inhibitors of urokinase plasminogen activator
07/06/1995WO1995016435A3 Improved intraocular irrigating solution containing non-steroidal antiinflammatory agent
07/06/1995WO1995016038A3 Humanized antibodies and uses thereof
07/06/1995WO1995011984A3 Recombinant adenoviral vector and methods of use
07/06/1995DE4344397A1 New human circulating cytokine CC-1 and related nucleic acid
07/06/1995DE19500030A1 New mpl ligand polypeptide, thrombopoietin
07/06/1995CA2682117A1 The use of the neurotoxic component of a botulinum toxin for the treatment of a facial disease, disorder or condition
07/06/1995CA2589968A1 The use of the neurotoxic component of a botulinum toxin for the treatment of pain associated with muscle activity or contracture
07/06/1995CA2300771A1 Method for treating a mucus secretion
07/06/1995CA2300723A1 Method for treating pain associated with a muscle disorder
07/06/1995CA2300451A1 Method for treating a pyloric valve disease
07/06/1995CA2300433A1 Method for treating a lacrimation disorder
07/06/1995CA2180359A1 Ileal bile acid transporter compositions and methods
07/06/1995CA2180262A1 Method for selective methionine starvation of malignant cells in mammals
07/06/1995CA2180140A1 Methods and compositions for inhibiting thrombogenesis
07/06/1995CA2180019A1 Homologous recombination for universal donor cells and chimeric mammalian hosts
07/06/1995CA2179638A1 Human circulating cytokine cc-1
07/06/1995CA2156924A1 Water soluble non-immunogenic polyamide cross-linking agents
07/05/1995EP0661295A1 Cedar pollen protein and uses thereof
07/05/1995EP0661294A1 Cedar pollen protein and uses thereof
07/05/1995EP0661293A2 Protein having cell growth-stimulating and macrophage chemotactic actions, preparative method therefor and use thereof
07/05/1995EP0661292A1 Orally active renin inhibitors
07/05/1995EP0661260A1 New bi-aromatic compounds derived from amides pharmaceutical compositions and cosmetic compositions containing them and their use
07/05/1995EP0661058A1 Use of bradykinin antagonists for the treatment of viral diseases
07/05/1995EP0661057A1 Hematopoietic cell proliferation accelerator
07/05/1995EP0660723A1 Vp6 encapsulated drug delivery.
07/05/1995EP0660721A1 Monoclonal antibodies that block ligand binding to the cd22 receptor in mature b cells
07/05/1995EP0660717A1 Aminosteroids for ophthalmic use
07/05/1995EP0660710A1 Compositions of n-(phosphonoacetyl)-l-aspartic acid and methods of their use as broad spectrum antivirals
07/05/1995EP0660709A1 Creatine analogs having antiviral activity
07/05/1995EP0396719B1 Neurite growth regulatory factors
07/05/1995EP0362218B1 IMPROVED METHOD FOR PRODUCING FACTOR VIII:c-TYPE PROTEINS
07/05/1995EP0328634B1 Pharmaceutical compositions for the treatment of psoriasis
07/05/1995CN1104634A Compounds with a sulphamoyl and amidino group, process for preparing them and pharmaceutical compositions containing them
07/05/1995CN1104537A Nutriment
07/05/1995CN1104504A Growth hormone for hepatocyte
07/05/1995CN1104488A Sustained releasable parenteral pharmaceutical preparations and method of producing the same
07/05/1995CN1029227C Composition for denatured denaturation or protection agent for nerve cell and process for preparing benzene derivatives used for composition
07/04/1995US5430155 1,4-diamine-2,3-dihydroxy butanes
07/04/1995US5430151 Trifluoromethyl-containing pseudopeptides active against retroviruses
07/04/1995US5430150 N-(1-(((1H-benzimidazol-2-ylmethyl)amino)carbonyl)-2-methyl -butyl)-3-(((1,1-dimethylethyl)amino)-carbonyl)decahydro-gamma-hydroxyalpha -(phenylmethyl)-2-isoquinolinepentanamide compounds; AIDS
07/04/1995US5430145 Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
07/04/1995US5430128 Peptidyl derivatives as inhibitors of interleukin-1β converting enzyme
07/04/1995US5430045 Administering an L-2-oxothiazolidine-4-carboxylate to patient receiving AZT
07/04/1995US5430025 Elastase-inhibiting peptides bearing a C-terminal trifluoromethylketone moiety
07/04/1995US5430024 Peptides bearing N-terminal amidino moieties and their use as inhibitors of platelet aggregation
07/04/1995US5430023 Tripeptide antithrombotic agents
07/04/1995US5430022 Endothelin antagonists; hypotensive agents; treatment for angina pectoris, brain disorders, asthma, renal failure
07/04/1995US5430021 Hydrophobic drug delivery systems
07/04/1995US5430020 Recombinant alveolar surfactant protein
07/04/1995US5430019 Homogeneous K-FGF and use of the same
07/04/1995US5430018 Cyclohexapeptide with basic nitrogen containing alkylamide groups
07/04/1995US5430017 Oral pharmaceutical composition containing cyclosporin and process for preparing same
07/04/1995US5430016 Insulin compounds and compositions
07/04/1995US5429938 Methods and compositions for isolation and growth of kidney tubule stem cells, in vitro kidney tubulogenesis and ex vivo construction of renal tubules
07/04/1995US5429937 Method for recovering purified 100,000 molecular weight fraction of human pancreatic cholesterol esterase using heparin agarose
07/04/1995US5429921 Suspending a eukaryotic cell expressing heterologous calcium channels in a solution, depolarizing the cell membrane, detecting current flow into the cell and comparing current flow to control cells
07/04/1995CA1336223C Method of chain combination
07/04/1995CA1336166C Further improvements relating to drug delivery systems
06/1995
06/29/1995WO1995017673A1 Ocular diagnostics and therapies
06/29/1995WO1995017506A1 Mediators of chronic allograft rejection
06/29/1995WO1995017428A1 Method for preparing collagen from cnidarians, and resulting cosmetic compositions
06/29/1995WO1995017426A1 Peptide effective as substrate and/or inhibitor of the transglutaminase enzyme and use thereof for diagnostics and therapeutics
06/29/1995WO1995017424A1 NOVEL RECOMBINANT DerI ALLERGENIC SUBSTANCE, PRECURSOR THEREOF, AND PROCESS FOR PRODUCING THEM
06/29/1995WO1995017423A1 Compounds with growth hormone releasing properties
06/29/1995WO1995017422A1 Compounds with growth hormone releasing properties
06/29/1995WO1995017421A1 PEPTIDE ANALOGS OF THE FACTOR IXa PLATELET BINDING SITE
06/29/1995WO1995017420A1 Peptide analogs of the activated platelet binding site on factor xi
06/29/1995WO1995017419A1 Metal chelators
06/29/1995WO1995017416A1 Dna encoding the wnt-x growth factor
06/29/1995WO1995017414A1 Anti-hepatitis b viral oligonucleotides
06/29/1995WO1995017412A1 NOVEL HUMAN β2 INTEGRIN ALPHA SUBUNIT
06/29/1995WO1995017378A1 Compound capable of introducing at least one molecule into a cell
06/29/1995WO1995017213A1 P53-based polypeptide fragments, nucleic acid molecules encoding same, and uses thereof
06/29/1995WO1995017207A1 Parathyroid hormone formulation
06/29/1995WO1995017206A1 Lyophilized stem cell factor formulations
06/29/1995WO1995017205A1 Recombinant human thymopoietin proteins and uses therefor
06/29/1995WO1995017204A1 Composition and methods to improve neural outcome
06/29/1995WO1995017203A1 Novel nucleic acid sequences isolated from glial cells
06/29/1995WO1995017202A1 Method of preventing or treating disease characterized by neoplastic cells expressing cd40
06/29/1995WO1995017198A1 A novel tumor suppressor gene
06/29/1995WO1995017181A1 Biologically active 3-substituted oxindole derivatives useful as anti-angiogenic agents
06/29/1995WO1995017093A1 New cryptophycins
06/29/1995WO1995017092A1 MACROPHAGE INFLAMMATORY PROTEINS-3, -4 AND -1¿η?
06/29/1995WO1995014085A3 A method for detection of alterations in the dna mismatch repair pathway
06/29/1995DE4334927C1 Use of lithium salts
06/29/1995CA2179606A1 Macrophage inflammatory proteins-3, -4 and -1.gamma.
06/29/1995CA2179598A1 Compounds with growth hormone releasing properties
06/29/1995CA2179597A1 Compounds with growth hormone releasing properties
06/29/1995CA2179490A1 New cryptophycins
06/29/1995CA2179385A1 Compound capable of introducing at least one molecule into a cell
06/29/1995CA2179379A1 Metal chelators
06/29/1995CA2179196A1 Method of preventing or treating disease characterized by neoplastic cells expressing cd40
06/29/1995CA2178811A1 Anti-hepatitis b viral oligonucleotides
06/29/1995CA2178745A1 A novel tumor suppressor gene
1 ... 2839 2840 2841 2842 2843 2844 2845 2846 2847 2848 2849 2850 2851 2852 2853 2854 2855 2856 2857 2858 2859 ... 3163